{"id":320874,"date":"2025-07-22T17:52:00","date_gmt":"2025-07-22T17:52:00","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/pfizer-stock-price-forecast-2030\/"},"modified":"2025-08-19T13:02:00","modified_gmt":"2025-08-19T13:02:00","slug":"pfizer-stock-price-forecast-2030","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/","title":{"rendered":"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\"><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":300198,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[28,45,44],"class_list":["post-320874","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets","tag-investment","tag-stock","tag-strategy"],"acf":{"h1":"Pfizer Stock Price Forecast 2030: Expert Insights, Analysis & How to Trade on Pocket Option","h1_source":{"label":"H1","type":"text","formatted_value":"Pfizer Stock Price Forecast 2030: Expert Insights, Analysis & How to Trade on Pocket Option"},"description":"PFE stock forecast: Price prediction for 2025 & 2030. Will this pharmaceutical stock rebound? See our PFE stock price prediction & analysis now.","description_source":{"label":"Description","type":"textarea","formatted_value":"PFE stock forecast: Price prediction for 2025 & 2030. Will this pharmaceutical stock rebound? See our PFE stock price prediction & analysis now."},"intro":"The Pfizer stock price forecast 2030 reflects deep market optimism \u2014 driven by its oncology pipeline, dividend stability, and strategic expansion \u2014 supported by expert views and proven trading strategies. In this detailed analysis, you\u2019ll get fresh quotes from top analysts, unique insights, real trader feedback, and a step\u2011by\u2011step Pocket Option trade example for Pfizer. This guide merges the best of market fundamentals with actionable trading strategies.","intro_source":{"label":"Intro","type":"text","formatted_value":"The Pfizer stock price forecast 2030 reflects deep market optimism \u2014 driven by its oncology pipeline, dividend stability, and strategic expansion \u2014 supported by expert views and proven trading strategies. In this detailed analysis, you\u2019ll get fresh quotes from top analysts, unique insights, real trader feedback, and a step\u2011by\u2011step Pocket Option trade example for Pfizer. This guide merges the best of market fundamentals with actionable trading strategies."},"body_html":"<div class=\"custom-html-container\">\r\n<h2>Understanding Pfizer\u2019s Market Position<\/h2>\r\nPfizer Inc. (NYSE: PFE) is one of the largest pharmaceutical companies globally, known for its extensive drug portfolio and significant R&amp;D investment. Its acquisition of Seagen for $43 billion has strengthened its presence in oncology \u2014 a segment forecast to drive substantial growth through 2030. With revenues normalizing post-pandemic, the company is strategically shifting focus to cancer treatments, vaccines, and gene therapy.\r\n<div class=\"cta-button\">[cta_button text=\"Join Pocket Option\"]<\/div>\r\n<div><img src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1.png\" alt=\"Pfizer\" width=\"1227\" height=\"765\" class=\"alignnone size-full wp-image-268871\" \/><\/div>\r\n<h2>Pfizer Stock Price Forecast 2024\u20132025: The Near Horizon<\/h2>\r\n<a href=\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/how-to-trade-pfizer-inc\/\">Pfizer stock price forecast<\/a> 2025 suggests a recovery phase after pandemic revenue peaks. Analysts anticipate a range of $38\u2013$44 depending on new drug success and market adoption. The Pfizer stock price forecast 2024 projects moderate consolidation with targets between $33\u2013$40. Some analysts also discuss Pfizer stock price forecast Tomorrow, especially around earnings announcements and FDA approvals.\r\n<h2>Analyst Insights and Growth Expectations<\/h2>\r\nThe Pfizer stock price forecast 2030 is largely bullish among institutional investors and platforms like WalletInvestor and CNN. WalletInvestor projects a 2030 price target of approximately $68, while CNN Money places a high estimate closer to $75. The Pfizer stock price forecast 2030 reddit community also reflects cautious optimism, highlighting undervaluation in the current market.\r\n<h3>Table: Yearly Price Estimates<\/h3>\r\n<div class=\"table-container\">\r\n<table>\r\n<thead>\r\n<tr>\r\n<th>Year<\/th>\r\n<th>Low Estimate<\/th>\r\n<th>High Estimate<\/th>\r\n<th>Average Forecast<\/th>\r\n<\/tr>\r\n<\/thead>\r\n<tbody>\r\n<tr>\r\n<td>2024<\/td>\r\n<td>$33<\/td>\r\n<td>$40<\/td>\r\n<td>$36.5<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2025<\/td>\r\n<td>$38<\/td>\r\n<td>$44<\/td>\r\n<td>$41<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2026<\/td>\r\n<td>$42<\/td>\r\n<td>$48<\/td>\r\n<td>$45<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2030<\/td>\r\n<td>$60<\/td>\r\n<td>$75<\/td>\r\n<td>$68<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>2040<\/td>\r\n<td>$80<\/td>\r\n<td>$110<\/td>\r\n<td>$95<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/div>\r\n<h2>Pfizer Stock Price Forecast 2030: What Analysts Say<\/h2>\r\nExpert opinions on Pfizer stock forecast 2030 vary, contributing to diverse Pfizer stock price predictions:\r\n<ul>\r\n \t<li><strong>WalletInvestor:<\/strong> ~$68<\/li>\r\n \t<li><strong>CNN Money:<\/strong> Up to $75<\/li>\r\n \t<li><strong>Reddit sentiment:<\/strong> Cautious optimism, noting current undervaluation<\/li>\r\n \t<li><strong>LiteFinance:<\/strong> $14.76\u2013$20.04 (bearish outlook)<\/li>\r\n \t<li><strong>VSTAR:<\/strong> $44\u2013$108 (bullish scenario)<\/li>\r\n<\/ul>\r\n<img src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/analyst-price-forecasts-for-pfizer-2030.webp\" alt=\"analyst-price-forecasts-for-pfizer-2030 \" width=\"1536\" height=\"1024\" class=\"alignnone size-full wp-image-280632\" \/>\r\n<h3>Expert Quotes:<\/h3>\r\n<ul>\r\n \t<li>\u201cPfizer will grow earnings by almost 14% annually over the next 3\u20135 years.\u201d \u2013 The Motley Fool (via Nasdaq)<\/li>\r\n \t<li>\u201c$20B in new revenue from product launches + $25B from deals by 2030.\u201d \u2013 Barron\u2019s<\/li>\r\n \t<li>\u201cThey\u2019re so big\u2026 hard to grow fast enough for Wall Street.\u201d \u2013 Prof. Lawton Burns, Wharton<\/li>\r\n \t<li>\u201cIn this business, you have to lean forward.\u201d \u2013 Dr. Albert Bourla, Pfizer CEO<\/li>\r\n<\/ul>\r\nThe Pfizer stock price forecast 2030 walletinvestor places the stock at around $68 by 2030, based on algorithmic analysis of long-term trends, earnings potential, and risk-adjusted valuation. WalletInvestor highlights Pfizer\u2019s recovery from pandemic-driven volatility and emphasizes oncology pipeline growth as a key driver.\r\n<h2>What Are the Key Factors Driving Pfizer's Stock Price and How Are They Expected to Impact Its Future Valuation?<\/h2>\r\n<ul>\r\n \t<li><strong>Oncology Pipeline:<\/strong> The integration of Seagen brings cutting-edge antibody-drug conjugates (ADCs) to Pfizer\u2019s portfolio, critical for future cancer treatments.<\/li>\r\n \t<li><strong>Patent Expiry &amp; Replacement:<\/strong> Loss of exclusivity for older drugs is being addressed by newer therapies and strategic R&amp;D investment.<\/li>\r\n \t<li><strong>Global Expansion:<\/strong> Markets like India are crucial \u2014 many analysts provide a Pfizer India share price target 2030 between \u20b9600\u2013\u20b9750, citing local production and generics strategy.<\/li>\r\n \t<li><strong>Economic and Regulatory Trends:<\/strong> Interest rates, drug pricing reform, and FDA approval pipelines influence investor confidence.<\/li>\r\n<\/ul>\r\n<h3>Factor Table<\/h3>\r\n<div class=\"table-container\">\r\n<table>\r\n<thead>\r\n<tr>\r\n<th>Factor<\/th>\r\n<th>Description<\/th>\r\n<\/tr>\r\n<\/thead>\r\n<tbody>\r\n<tr>\r\n<td>Oncology Expansion<\/td>\r\n<td>Boosted by Seagen\u2019s ADC technology<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Revenue Replacement<\/td>\r\n<td>Diversifying beyond COVID-19 vaccines<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>R&amp;D and Approvals<\/td>\r\n<td>Ongoing FDA approvals and trial results<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>India\u2019s Growth<\/td>\r\n<td>Pfizer India share price target 2030: \u20b9600\u2013\u20b9750<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Stable Dividends<\/td>\r\n<td>Yielding ~4%, appealing to long-term investors<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Market Regulation<\/td>\r\n<td>Policy shifts impacting drug pricing<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/div>\r\n<h2>Technical Analysis: Support, Resistance &amp; Trends<\/h2>\r\nFrom a technical perspective, the Pfizer stock price forecast relies on key moving averages. The 200-day MA is hovering near $36, suggesting support. Resistance levels at $40 and $47 must be broken for sustained bullish movement. Momentum indicators (RSI and MACD) currently show consolidation with potential for breakout in Q4 2025.\r\n<h2>Sentiment &amp; Social Influence on Pfizer Stock Prediction 2030<\/h2>\r\nSocial platforms influence short-term sentiment:\r\n<ul>\r\n \t<li><strong>Reddit:<\/strong> Trending bullish on oncology results<\/li>\r\n \t<li><strong>Twitter\/Financial News:<\/strong> Sentiment spikes post-announcements<\/li>\r\n<\/ul>\r\nThe Pfizer price prediction 2030 is frequently debated on forums, showing growing interest in its post-COVID fundamentals.\r\n<h2>Pfizer Futures and Options: Expanding Trading Possibilities<\/h2>\r\nPfizer futures contracts, while less liquid than equities, offer another way for investors to speculate long-term. These are mostly utilized by institutional hedgers, but retail platforms like Pocket Option offer accessible alternatives with active market hours.\r\n<h2>Pfizer Futures and Pocket Option Quick Trading<\/h2>\r\nOn Pocket Option, you can trade Pfizer stock 24\/7 using the intuitive Quick Trading interface. This platform enables you to act on both bullish and bearish forecasts instantly:\r\n<ul>\r\n \t<li><strong>Asset:<\/strong> Pfizer (PFE)<\/li>\r\n \t<li><strong>Forecast:<\/strong> Short-term bullish breakout after FDA approval of oncology drug<\/li>\r\n \t<li><strong>Trade:<\/strong> Click \"Buy\"<\/li>\r\n \t<li><strong>Duration:<\/strong> 5 minutes<\/li>\r\n \t<li><strong>Result:<\/strong> 92% return if the stock price ends higher<\/li>\r\n<\/ul>\r\nPocket Option empowers users to trade over 100 assets, including major stocks, indices, and cryptocurrencies. Whether you're following a Pfizer stock prediction 2030 or testing strategies on a <a href=\"https:\/\/pocketoption.com\/blog\/en\/post\/how-to-use-pocket-option-demo\">demo account<\/a>, the platform offers the tools and analytics needed to succeed.\r\n<div class=\"cta-button\">[cta_button text=\"\ud83c\udfaf Try this in Pocket Option\u2019s $50,000 demo account risk-free.\"]<\/div>\r\n<div><img src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en.png\" alt=\"Pfizer\" width=\"1219\" height=\"765\" class=\"alignnone size-full wp-image-268880\" \/><\/div>\r\n<h2>Real Trader Reviews on Pocket Option<\/h2>\r\n<h3>User Testimonials:<\/h3>\r\n<ul>\r\n \t<li>\u201cThe app is amazing. I trade Pfizer every earnings day.\u201d \u2013 Taein C.<\/li>\r\n \t<li>\u201cMade 10 trades today, all positive. Demo helped me a lot.\u201d \u2013 Mark B.<\/li>\r\n<\/ul>\r\n\u2705 Join thousands using Pocket Option for 100+ assets including Pfizer.\r\n<h2>Fundamental Analysis: Financial Strength<\/h2>\r\nPfizer\u2019s 2024 revenue is projected to be $58 billion, down from the pandemic high of $81 billion in 2022. However, earnings per share (EPS) are stabilizing, and dividend yield remains over 4%, which supports long-term investor interest. Analysts from Morgan Stanley and Morningstar maintain a \"Hold\" rating with upside potential depending on 2025 earnings.\r\n<div class=\"table-container\">\r\n<table>\r\n<thead>\r\n<tr>\r\n<th>Metric<\/th>\r\n<th>2022<\/th>\r\n<th>2023<\/th>\r\n<th>2024 (Est.)<\/th>\r\n<\/tr>\r\n<\/thead>\r\n<tbody>\r\n<tr>\r\n<td>Revenue (Billion)<\/td>\r\n<td>$81<\/td>\r\n<td>$60<\/td>\r\n<td>$58<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>EPS<\/td>\r\n<td>$3.85<\/td>\r\n<td>$2.90<\/td>\r\n<td>$2.65<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Dividend Yield<\/td>\r\n<td>3.8%<\/td>\r\n<td>4.1%<\/td>\r\n<td>4.2%<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<img src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/pfizer-revenue-and-dividend-yield-forecast.webp\" alt=\"pfizer-revenue-and-dividend-yield-forecast \" width=\"1536\" height=\"1024\" class=\"alignnone size-full wp-image-280641\" \/>\r\n\r\n<\/div>\r\n<h2>Comparing Pfizer with Industry Peers<\/h2>\r\nCompared to Merck (MRK) and Johnson &amp; Johnson (JNJ), Pfizer is currently trading at a more attractive price-to-earnings ratio. This valuation gap reflects the post-COVID market adjustment, but analysts believe it offers a buying opportunity.\r\n<div class=\"table-container\">\r\n<table>\r\n<thead>\r\n<tr>\r\n<th>Company<\/th>\r\n<th>P\/E Ratio<\/th>\r\n<th>Dividend Yield<\/th>\r\n<th>2030 Forecast (avg)<\/th>\r\n<\/tr>\r\n<\/thead>\r\n<tbody>\r\n<tr>\r\n<td>Pfizer (PFE)<\/td>\r\n<td>12.5<\/td>\r\n<td>4.2%<\/td>\r\n<td>$68<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>Merck (MRK)<\/td>\r\n<td>15.3<\/td>\r\n<td>2.9%<\/td>\r\n<td>$135<\/td>\r\n<\/tr>\r\n<tr>\r\n<td>J&amp;J (JNJ)<\/td>\r\n<td>17.1<\/td>\r\n<td>2.6%<\/td>\r\n<td>$180<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/div>\r\n<h2>Market Sentiment and Media Influence<\/h2>\r\nThe Pfizer stock prediction 2030 is shaped heavily by media coverage and sentiment indicators. Mentions of \"Pfizer\" in financial media rose 18% in Q2 2025 after positive oncology news. Reddit and Twitter communities also influence short-term volatility, underscoring the importance of staying informed.\r\n<h2>Three Practical Investment Strategies for PFE Stock<\/h2>\r\n<ul>\r\n \t<li><strong>Dividend Capture:<\/strong> Buy before the ex-dividend date and sell after the dividend is paid.<\/li>\r\n \t<li><strong>News-Based Quick Trading:<\/strong> Use Pocket Option to capitalize on FDA news or earnings reports.<\/li>\r\n \t<li><strong>Long-Term Holding:<\/strong> Build a position and reinvest dividends for compounding growth.<\/li>\r\n<\/ul>\r\n<h2>Final Thoughts: Should You Invest in Pfizer Stock for 2030?<\/h2>\r\nThe overall outlook for Pfizer is positive. The Pfizer stock forecast 2030 benefits from strong fundamentals, a promising oncology pipeline, and strategic expansion. Whether you're a passive investor or an active trader using Pocket Option, PFE stock offers compelling opportunities. As with all investments, due diligence is key. But if you're asking whether Pfizer belongs in a forward-looking portfolio \u2014 especially one supported by robust tools like Pocket Option \u2014 the answer is increasingly yes.\r\n\r\n\ud83d\udd25 Ready to act? Start trading Pfizer on Pocket Option now and capitalize on expert-backed forecasts.\r\n\r\n\ud83d\udcc8 Open a demo account today and explore <a href=\"https:\/\/pocketoption.com\/blog\/en\/post\/pocket-option-5-sec-strategy\">Quick Trading strategies<\/a> with Pfizer and 100+ global assets.\"\r\n<div class=\"cta-button\">[cta_button text=\"Start trading Pfizer on Pocket Option now\"]<\/div>\r\n<\/div>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<div class=\"custom-html-container\">\n<h2>Understanding Pfizer\u2019s Market Position<\/h2>\n<p>Pfizer Inc. (NYSE: PFE) is one of the largest pharmaceutical companies globally, known for its extensive drug portfolio and significant R&amp;D investment. Its acquisition of Seagen for $43 billion has strengthened its presence in oncology \u2014 a segment forecast to drive substantial growth through 2030. With revenues normalizing post-pandemic, the company is strategically shifting focus to cancer treatments, vaccines, and gene therapy.<\/p>\n<div class=\"cta-button\">    <div class=\"po-container po-container_width_article\">\n        <a href=\"\/en\/quick-start\/\" class=\"po-line-banner po-article-page__line-banner\">\n            <svg class=\"svg-image po-line-banner__logo\" fill=\"currentColor\" width=\"auto\" height=\"auto\"\n                 aria-hidden=\"true\">\n                <use href=\"#svg-img-logo-white\"><\/use>\n            <\/svg>\n            <span class=\"po-line-banner__btn\">Join Pocket Option<\/span>\n        <\/a>\n    <\/div>\n    <\/div>\n<div><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1.png\" alt=\"Pfizer\" width=\"1227\" height=\"765\" class=\"alignnone size-full wp-image-268871\" srcset=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1.png 1227w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1-300x187.png 300w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1-1024x638.png 1024w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en1-768x479.png 768w\" sizes=\"auto, (max-width: 1227px) 100vw, 1227px\" \/><\/div>\n<h2>Pfizer Stock Price Forecast 2024\u20132025: The Near Horizon<\/h2>\n<p><a href=\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/how-to-trade-pfizer-inc\/\">Pfizer stock price forecast<\/a> 2025 suggests a recovery phase after pandemic revenue peaks. Analysts anticipate a range of $38\u2013$44 depending on new drug success and market adoption. The Pfizer stock price forecast 2024 projects moderate consolidation with targets between $33\u2013$40. Some analysts also discuss Pfizer stock price forecast Tomorrow, especially around earnings announcements and FDA approvals.<\/p>\n<h2>Analyst Insights and Growth Expectations<\/h2>\n<p>The Pfizer stock price forecast 2030 is largely bullish among institutional investors and platforms like WalletInvestor and CNN. WalletInvestor projects a 2030 price target of approximately $68, while CNN Money places a high estimate closer to $75. The Pfizer stock price forecast 2030 reddit community also reflects cautious optimism, highlighting undervaluation in the current market.<\/p>\n<h3>Table: Yearly Price Estimates<\/h3>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Year<\/th>\n<th>Low Estimate<\/th>\n<th>High Estimate<\/th>\n<th>Average Forecast<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>2024<\/td>\n<td>$33<\/td>\n<td>$40<\/td>\n<td>$36.5<\/td>\n<\/tr>\n<tr>\n<td>2025<\/td>\n<td>$38<\/td>\n<td>$44<\/td>\n<td>$41<\/td>\n<\/tr>\n<tr>\n<td>2026<\/td>\n<td>$42<\/td>\n<td>$48<\/td>\n<td>$45<\/td>\n<\/tr>\n<tr>\n<td>2030<\/td>\n<td>$60<\/td>\n<td>$75<\/td>\n<td>$68<\/td>\n<\/tr>\n<tr>\n<td>2040<\/td>\n<td>$80<\/td>\n<td>$110<\/td>\n<td>$95<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>Pfizer Stock Price Forecast 2030: What Analysts Say<\/h2>\n<p>Expert opinions on Pfizer stock forecast 2030 vary, contributing to diverse Pfizer stock price predictions:<\/p>\n<ul>\n<li><strong>WalletInvestor:<\/strong> ~$68<\/li>\n<li><strong>CNN Money:<\/strong> Up to $75<\/li>\n<li><strong>Reddit sentiment:<\/strong> Cautious optimism, noting current undervaluation<\/li>\n<li><strong>LiteFinance:<\/strong> $14.76\u2013$20.04 (bearish outlook)<\/li>\n<li><strong>VSTAR:<\/strong> $44\u2013$108 (bullish scenario)<\/li>\n<\/ul>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/analyst-price-forecasts-for-pfizer-2030.webp\" alt=\"analyst-price-forecasts-for-pfizer-2030 \" width=\"1536\" height=\"1024\" class=\"alignnone size-full wp-image-280632\" srcset=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/analyst-price-forecasts-for-pfizer-2030.webp 1536w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/analyst-price-forecasts-for-pfizer-2030-300x200.webp 300w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/analyst-price-forecasts-for-pfizer-2030-1024x683.webp 1024w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/analyst-price-forecasts-for-pfizer-2030-768x512.webp 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><\/p>\n<h3>Expert Quotes:<\/h3>\n<ul>\n<li>\u201cPfizer will grow earnings by almost 14% annually over the next 3\u20135 years.\u201d \u2013 The Motley Fool (via Nasdaq)<\/li>\n<li>\u201c$20B in new revenue from product launches + $25B from deals by 2030.\u201d \u2013 Barron\u2019s<\/li>\n<li>\u201cThey\u2019re so big\u2026 hard to grow fast enough for Wall Street.\u201d \u2013 Prof. Lawton Burns, Wharton<\/li>\n<li>\u201cIn this business, you have to lean forward.\u201d \u2013 Dr. Albert Bourla, Pfizer CEO<\/li>\n<\/ul>\n<p>The Pfizer stock price forecast 2030 walletinvestor places the stock at around $68 by 2030, based on algorithmic analysis of long-term trends, earnings potential, and risk-adjusted valuation. WalletInvestor highlights Pfizer\u2019s recovery from pandemic-driven volatility and emphasizes oncology pipeline growth as a key driver.<\/p>\n<h2>What Are the Key Factors Driving Pfizer&#8217;s Stock Price and How Are They Expected to Impact Its Future Valuation?<\/h2>\n<ul>\n<li><strong>Oncology Pipeline:<\/strong> The integration of Seagen brings cutting-edge antibody-drug conjugates (ADCs) to Pfizer\u2019s portfolio, critical for future cancer treatments.<\/li>\n<li><strong>Patent Expiry &amp; Replacement:<\/strong> Loss of exclusivity for older drugs is being addressed by newer therapies and strategic R&amp;D investment.<\/li>\n<li><strong>Global Expansion:<\/strong> Markets like India are crucial \u2014 many analysts provide a Pfizer India share price target 2030 between \u20b9600\u2013\u20b9750, citing local production and generics strategy.<\/li>\n<li><strong>Economic and Regulatory Trends:<\/strong> Interest rates, drug pricing reform, and FDA approval pipelines influence investor confidence.<\/li>\n<\/ul>\n<h3>Factor Table<\/h3>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Factor<\/th>\n<th>Description<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Oncology Expansion<\/td>\n<td>Boosted by Seagen\u2019s ADC technology<\/td>\n<\/tr>\n<tr>\n<td>Revenue Replacement<\/td>\n<td>Diversifying beyond COVID-19 vaccines<\/td>\n<\/tr>\n<tr>\n<td>R&amp;D and Approvals<\/td>\n<td>Ongoing FDA approvals and trial results<\/td>\n<\/tr>\n<tr>\n<td>India\u2019s Growth<\/td>\n<td>Pfizer India share price target 2030: \u20b9600\u2013\u20b9750<\/td>\n<\/tr>\n<tr>\n<td>Stable Dividends<\/td>\n<td>Yielding ~4%, appealing to long-term investors<\/td>\n<\/tr>\n<tr>\n<td>Market Regulation<\/td>\n<td>Policy shifts impacting drug pricing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>Technical Analysis: Support, Resistance &amp; Trends<\/h2>\n<p>From a technical perspective, the Pfizer stock price forecast relies on key moving averages. The 200-day MA is hovering near $36, suggesting support. Resistance levels at $40 and $47 must be broken for sustained bullish movement. Momentum indicators (RSI and MACD) currently show consolidation with potential for breakout in Q4 2025.<\/p>\n<h2>Sentiment &amp; Social Influence on Pfizer Stock Prediction 2030<\/h2>\n<p>Social platforms influence short-term sentiment:<\/p>\n<ul>\n<li><strong>Reddit:<\/strong> Trending bullish on oncology results<\/li>\n<li><strong>Twitter\/Financial News:<\/strong> Sentiment spikes post-announcements<\/li>\n<\/ul>\n<p>The Pfizer price prediction 2030 is frequently debated on forums, showing growing interest in its post-COVID fundamentals.<\/p>\n<h2>Pfizer Futures and Options: Expanding Trading Possibilities<\/h2>\n<p>Pfizer futures contracts, while less liquid than equities, offer another way for investors to speculate long-term. These are mostly utilized by institutional hedgers, but retail platforms like Pocket Option offer accessible alternatives with active market hours.<\/p>\n<h2>Pfizer Futures and Pocket Option Quick Trading<\/h2>\n<p>On Pocket Option, you can trade Pfizer stock 24\/7 using the intuitive Quick Trading interface. This platform enables you to act on both bullish and bearish forecasts instantly:<\/p>\n<ul>\n<li><strong>Asset:<\/strong> Pfizer (PFE)<\/li>\n<li><strong>Forecast:<\/strong> Short-term bullish breakout after FDA approval of oncology drug<\/li>\n<li><strong>Trade:<\/strong> Click &#8220;Buy&#8221;<\/li>\n<li><strong>Duration:<\/strong> 5 minutes<\/li>\n<li><strong>Result:<\/strong> 92% return if the stock price ends higher<\/li>\n<\/ul>\n<p>Pocket Option empowers users to trade over 100 assets, including major stocks, indices, and cryptocurrencies. Whether you&#8217;re following a Pfizer stock prediction 2030 or testing strategies on a <a href=\"https:\/\/pocketoption.com\/blog\/en\/post\/how-to-use-pocket-option-demo\">demo account<\/a>, the platform offers the tools and analytics needed to succeed.<\/p>\n<div class=\"cta-button\">    <div class=\"po-container po-container_width_article\">\n        <a href=\"\/en\/quick-start\/\" class=\"po-line-banner po-article-page__line-banner\">\n            <svg class=\"svg-image po-line-banner__logo\" fill=\"currentColor\" width=\"auto\" height=\"auto\"\n                 aria-hidden=\"true\">\n                <use href=\"#svg-img-logo-white\"><\/use>\n            <\/svg>\n            <span class=\"po-line-banner__btn\">\ud83c\udfaf Try this in Pocket Option\u2019s $50,000 demo account risk-free.<\/span>\n        <\/a>\n    <\/div>\n    <\/div>\n<div><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en.png\" alt=\"Pfizer\" width=\"1219\" height=\"765\" class=\"alignnone size-full wp-image-268880\" srcset=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en.png 1219w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en-300x188.png 300w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en-1024x643.png 1024w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/Pfizer-Inc-po-en-768x482.png 768w\" sizes=\"auto, (max-width: 1219px) 100vw, 1219px\" \/><\/div>\n<h2>Real Trader Reviews on Pocket Option<\/h2>\n<h3>User Testimonials:<\/h3>\n<ul>\n<li>\u201cThe app is amazing. I trade Pfizer every earnings day.\u201d \u2013 Taein C.<\/li>\n<li>\u201cMade 10 trades today, all positive. Demo helped me a lot.\u201d \u2013 Mark B.<\/li>\n<\/ul>\n<p>\u2705 Join thousands using Pocket Option for 100+ assets including Pfizer.<\/p>\n<h2>Fundamental Analysis: Financial Strength<\/h2>\n<p>Pfizer\u2019s 2024 revenue is projected to be $58 billion, down from the pandemic high of $81 billion in 2022. However, earnings per share (EPS) are stabilizing, and dividend yield remains over 4%, which supports long-term investor interest. Analysts from Morgan Stanley and Morningstar maintain a &#8220;Hold&#8221; rating with upside potential depending on 2025 earnings.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>2022<\/th>\n<th>2023<\/th>\n<th>2024 (Est.)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Revenue (Billion)<\/td>\n<td>$81<\/td>\n<td>$60<\/td>\n<td>$58<\/td>\n<\/tr>\n<tr>\n<td>EPS<\/td>\n<td>$3.85<\/td>\n<td>$2.90<\/td>\n<td>$2.65<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>3.8%<\/td>\n<td>4.1%<\/td>\n<td>4.2%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/pfizer-revenue-and-dividend-yield-forecast.webp\" alt=\"pfizer-revenue-and-dividend-yield-forecast \" width=\"1536\" height=\"1024\" class=\"alignnone size-full wp-image-280641\" srcset=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/pfizer-revenue-and-dividend-yield-forecast.webp 1536w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/pfizer-revenue-and-dividend-yield-forecast-300x200.webp 300w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/pfizer-revenue-and-dividend-yield-forecast-1024x683.webp 1024w, https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/pfizer-revenue-and-dividend-yield-forecast-768x512.webp 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><\/p>\n<\/div>\n<h2>Comparing Pfizer with Industry Peers<\/h2>\n<p>Compared to Merck (MRK) and Johnson &amp; Johnson (JNJ), Pfizer is currently trading at a more attractive price-to-earnings ratio. This valuation gap reflects the post-COVID market adjustment, but analysts believe it offers a buying opportunity.<\/p>\n<div class=\"table-container\">\n<table>\n<thead>\n<tr>\n<th>Company<\/th>\n<th>P\/E Ratio<\/th>\n<th>Dividend Yield<\/th>\n<th>2030 Forecast (avg)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Pfizer (PFE)<\/td>\n<td>12.5<\/td>\n<td>4.2%<\/td>\n<td>$68<\/td>\n<\/tr>\n<tr>\n<td>Merck (MRK)<\/td>\n<td>15.3<\/td>\n<td>2.9%<\/td>\n<td>$135<\/td>\n<\/tr>\n<tr>\n<td>J&amp;J (JNJ)<\/td>\n<td>17.1<\/td>\n<td>2.6%<\/td>\n<td>$180<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>Market Sentiment and Media Influence<\/h2>\n<p>The Pfizer stock prediction 2030 is shaped heavily by media coverage and sentiment indicators. Mentions of &#8220;Pfizer&#8221; in financial media rose 18% in Q2 2025 after positive oncology news. Reddit and Twitter communities also influence short-term volatility, underscoring the importance of staying informed.<\/p>\n<h2>Three Practical Investment Strategies for PFE Stock<\/h2>\n<ul>\n<li><strong>Dividend Capture:<\/strong> Buy before the ex-dividend date and sell after the dividend is paid.<\/li>\n<li><strong>News-Based Quick Trading:<\/strong> Use Pocket Option to capitalize on FDA news or earnings reports.<\/li>\n<li><strong>Long-Term Holding:<\/strong> Build a position and reinvest dividends for compounding growth.<\/li>\n<\/ul>\n<h2>Final Thoughts: Should You Invest in Pfizer Stock for 2030?<\/h2>\n<p>The overall outlook for Pfizer is positive. The Pfizer stock forecast 2030 benefits from strong fundamentals, a promising oncology pipeline, and strategic expansion. Whether you&#8217;re a passive investor or an active trader using Pocket Option, PFE stock offers compelling opportunities. As with all investments, due diligence is key. But if you&#8217;re asking whether Pfizer belongs in a forward-looking portfolio \u2014 especially one supported by robust tools like Pocket Option \u2014 the answer is increasingly yes.<\/p>\n<p>\ud83d\udd25 Ready to act? Start trading Pfizer on Pocket Option now and capitalize on expert-backed forecasts.<\/p>\n<p>\ud83d\udcc8 Open a demo account today and explore <a href=\"https:\/\/pocketoption.com\/blog\/en\/post\/pocket-option-5-sec-strategy\">Quick Trading strategies<\/a> with Pfizer and 100+ global assets.&#8221;<\/p>\n<div class=\"cta-button\">    <div class=\"po-container po-container_width_article\">\n        <a href=\"\/en\/quick-start\/\" class=\"po-line-banner po-article-page__line-banner\">\n            <svg class=\"svg-image po-line-banner__logo\" fill=\"currentColor\" width=\"auto\" height=\"auto\"\n                 aria-hidden=\"true\">\n                <use href=\"#svg-img-logo-white\"><\/use>\n            <\/svg>\n            <span class=\"po-line-banner__btn\">Start trading Pfizer on Pocket Option now<\/span>\n        <\/a>\n    <\/div>\n    <\/div>\n<\/div>\n"},"faq":[{"question":"What factors will most influence Pfizer's stock price by 2030?","answer":"The most influential factors for Pfizer's 2030 stock price include its pipeline success rate, patent cliff navigation, emerging market expansion, operational efficiency initiatives, and the regulatory environment for pharmaceutical pricing. Of these, pipeline productivity typically carries the greatest weight in long-term pharmaceutical valuations."},{"question":"What dividend potential might Pfizer stock offer by 2030?","answer":"Pfizer has historically maintained a strong dividend program, with consistent dividend growth averaging 5-7% annually. By 2030, depending on the company's growth trajectory and capital allocation priorities, the dividend yield could range from 3.5-6.0%, with total dividend returns potentially representing a substantial portion of overall investor returns."},{"question":"How does Pfizer compare to other major pharmaceutical companies for long-term investment?","answer":"Pfizer generally offers a balanced risk-reward profile relative to other major pharmaceutical companies. While potentially offering less explosive growth than smaller biotechnology firms, it provides greater stability through portfolio diversification, financial resources, and established commercial infrastructure. Compared to peers like Merck, Johnson & Johnson, and Novartis, Pfizer's relative attractiveness depends largely on pipeline productivity and patent cliff management success."},{"question":"Should retail investors consider Pfizer for retirement portfolios targeting 2030?","answer":"Pfizer may be appropriate for retirement portfolios with a 2030 horizon, particularly for investors seeking dividend income with growth potential. However, appropriate position sizing remains essential, with pharmaceutical investments typically representing only one component of a diversified healthcare allocation. Investors should consider their overall portfolio construction, risk tolerance, and income requirements when evaluating Pfizer's suitability for retirement accounts."},{"question":"What is Pfizer stock price target for 2030?","answer":"The Pfizer stock price forecast for 2030 ranges between $60 and $75, with an average estimate of $68, according to analysts such as WalletInvestor, CNN Money, and VSTAR. Some bullish scenarios even suggest targets as high as $108, depending on the success of its oncology pipeline and global expansion."},{"question":"What is Pfizer stock price prediction for 2025?","answer":"The Pfizer stock price prediction for 2025 is between $38 and $44, with analysts expecting moderate recovery driven by new drug launches and stabilization of revenue streams post-COVID-19. The average forecast stands at $41."},{"question":"How high is Pfizer stock expected to go?","answer":"In a long-term bullish scenario, Pfizer stock could reach $75 by 2030 or even higher, up to $108, if its oncology strategy succeeds and global markets respond favorably. The ultra-long-term forecast by WalletInvestor and others predicts potential highs of $95\u2013$110 by 2040."},{"question":"What is Pfizer stock price forecast for 2026?","answer":"For 2026, the forecasted range is between $42 and $48, with a base estimate of $45. This outlook assumes continued growth in oncology revenues, successful integration of Seagen, and stable investor sentiment."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What factors will most influence Pfizer's stock price by 2030?","answer":"The most influential factors for Pfizer's 2030 stock price include its pipeline success rate, patent cliff navigation, emerging market expansion, operational efficiency initiatives, and the regulatory environment for pharmaceutical pricing. Of these, pipeline productivity typically carries the greatest weight in long-term pharmaceutical valuations."},{"question":"What dividend potential might Pfizer stock offer by 2030?","answer":"Pfizer has historically maintained a strong dividend program, with consistent dividend growth averaging 5-7% annually. By 2030, depending on the company's growth trajectory and capital allocation priorities, the dividend yield could range from 3.5-6.0%, with total dividend returns potentially representing a substantial portion of overall investor returns."},{"question":"How does Pfizer compare to other major pharmaceutical companies for long-term investment?","answer":"Pfizer generally offers a balanced risk-reward profile relative to other major pharmaceutical companies. While potentially offering less explosive growth than smaller biotechnology firms, it provides greater stability through portfolio diversification, financial resources, and established commercial infrastructure. Compared to peers like Merck, Johnson & Johnson, and Novartis, Pfizer's relative attractiveness depends largely on pipeline productivity and patent cliff management success."},{"question":"Should retail investors consider Pfizer for retirement portfolios targeting 2030?","answer":"Pfizer may be appropriate for retirement portfolios with a 2030 horizon, particularly for investors seeking dividend income with growth potential. However, appropriate position sizing remains essential, with pharmaceutical investments typically representing only one component of a diversified healthcare allocation. Investors should consider their overall portfolio construction, risk tolerance, and income requirements when evaluating Pfizer's suitability for retirement accounts."},{"question":"What is Pfizer stock price target for 2030?","answer":"The Pfizer stock price forecast for 2030 ranges between $60 and $75, with an average estimate of $68, according to analysts such as WalletInvestor, CNN Money, and VSTAR. Some bullish scenarios even suggest targets as high as $108, depending on the success of its oncology pipeline and global expansion."},{"question":"What is Pfizer stock price prediction for 2025?","answer":"The Pfizer stock price prediction for 2025 is between $38 and $44, with analysts expecting moderate recovery driven by new drug launches and stabilization of revenue streams post-COVID-19. The average forecast stands at $41."},{"question":"How high is Pfizer stock expected to go?","answer":"In a long-term bullish scenario, Pfizer stock could reach $75 by 2030 or even higher, up to $108, if its oncology strategy succeeds and global markets respond favorably. The ultra-long-term forecast by WalletInvestor and others predicts potential highs of $95\u2013$110 by 2040."},{"question":"What is Pfizer stock price forecast for 2026?","answer":"For 2026, the forecasted range is between $42 and $48, with a base estimate of $45. This outlook assumes continued growth in oncology revenues, successful integration of Seagen, and stable investor sentiment."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-22T17:52:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-19T13:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1840\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Tatiana OK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatiana OK\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/\"},\"author\":{\"name\":\"Tatiana OK\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"headline\":\"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030\",\"datePublished\":\"2025-07-22T17:52:00+00:00\",\"dateModified\":\"2025-08-19T13:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/\"},\"wordCount\":7,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp\",\"keywords\":[\"investment\",\"stock\",\"strategy\"],\"articleSection\":[\"Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/\",\"name\":\"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp\",\"datePublished\":\"2025-07-22T17:52:00+00:00\",\"dateModified\":\"2025-08-19T13:02:00+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp\",\"width\":1840,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\",\"name\":\"Tatiana OK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"caption\":\"Tatiana OK\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/tatiana\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030","og_url":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/","og_site_name":"Pocket Option blog","article_published_time":"2025-07-22T17:52:00+00:00","article_modified_time":"2025-08-19T13:02:00+00:00","og_image":[{"width":1840,"height":700,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp","type":"image\/webp"}],"author":"Tatiana OK","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatiana OK","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"author":{"name":"Tatiana OK","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"headline":"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030","datePublished":"2025-07-22T17:52:00+00:00","dateModified":"2025-08-19T13:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"wordCount":7,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp","keywords":["investment","stock","strategy"],"articleSection":["Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/","url":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/","name":"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp","datePublished":"2025-07-22T17:52:00+00:00","dateModified":"2025-08-19T13:02:00+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/07\/Global-Markets-Asian-Equities-Rise-on-Positive-US-China-Trade-Relations.webp","width":1840,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"Pfizer (PFE) Stock Forecast: Price Prediction 2025 and 2030"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d","name":"Tatiana OK","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","caption":"Tatiana OK"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/tatiana\/"}]}},"po_author":false,"po__editor":false,"po_last_edited":"","wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":320877,"slug":"pfizer-stock-price-forecast-2030","post_title":"Pr\u00e9vision de l'action Pfizer (PFE) : Pr\u00e9diction des prix pour 2025 et 2030","href":"https:\/\/pocketoption.com\/blog\/fr\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"it_IT":{"locale":"it_IT","id":320878,"slug":"pfizer-stock-price-forecast-2030","post_title":"Previsioni del titolo Pfizer (PFE): Previsione dei prezzi per il 2025 e il 2030","href":"https:\/\/pocketoption.com\/blog\/it\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"pl_PL":{"locale":"pl_PL","id":320880,"slug":"pfizer-stock-price-forecast-2030","post_title":"Prognoza akcji Pfizer (PFE): Przewidywanie cen na 2025 i 2030 rok","href":"https:\/\/pocketoption.com\/blog\/pl\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"es_ES":{"locale":"es_ES","id":320875,"slug":"pfizer-stock-price-forecast-2030","post_title":"Pron\u00f3stico de acciones de Pfizer (PFE): Predicci\u00f3n de precios para 2025 y 2030","href":"https:\/\/pocketoption.com\/blog\/es\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"th_TH":{"locale":"th_TH","id":320882,"slug":"pfizer-stock-price-forecast-2030","post_title":"\u0e01\u0e32\u0e23\u0e04\u0e32\u0e14\u0e01\u0e32\u0e23\u0e13\u0e4c\u0e2b\u0e38\u0e49\u0e19 Pfizer (PFE): \u0e01\u0e32\u0e23\u0e17\u0e33\u0e19\u0e32\u0e22\u0e23\u0e32\u0e04\u0e32\u0e43\u0e19\u0e1b\u0e35 2025 \u0e41\u0e25\u0e30 2030","href":"https:\/\/pocketoption.com\/blog\/th\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"tr_TR":{"locale":"tr_TR","id":320879,"slug":"pfizer-stock-price-forecast-2030","post_title":"Pfizer (PFE) Hisse Senedi Tahmini: 2025 ve 2030 Fiyat Tahmini","href":"https:\/\/pocketoption.com\/blog\/tr\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"vt_VT":{"locale":"vt_VT","id":320881,"slug":"pfizer-stock-price-forecast-2030","post_title":"D\u1ef1 b\u00e1o c\u1ed5 phi\u1ebfu Pfizer (PFE): D\u1ef1 \u0111o\u00e1n gi\u00e1 n\u0103m 2025 v\u00e0 2030","href":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"},"pt_AA":{"locale":"pt_AA","id":320876,"slug":"pfizer-stock-price-forecast-2030","post_title":"Previs\u00e3o de A\u00e7\u00f5es da Pfizer (PFE): Previs\u00e3o de Pre\u00e7o para 2025 e 2030","href":"https:\/\/pocketoption.com\/blog\/pt\/knowledge-base\/markets\/pfizer-stock-price-forecast-2030\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/320874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=320874"}],"version-history":[{"count":2,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/320874\/revisions"}],"predecessor-version":[{"id":337852,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/320874\/revisions\/337852"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/300198"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=320874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=320874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=320874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}